Source:http://linkedlifedata.com/resource/pubmed/id/16897186
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5-6
|
pubmed:dateCreated |
2006-8-9
|
pubmed:abstractText |
Mucinous and clear cell adenocarcinomas are the major histological types of ovarian epithelial cancer and are associated with a poor prognosis due to their resistance to chemotherapy. A novel tumor marker specific for ovarian mucinous and clear cell adenocarcinomas would be helpful for overcoming these serious diseases. We showed previously by enzymological characterization and RT-PCR that colonic mucinous adenocarcinoma tissues ectopically express GlcNAc6ST-2, a member of the carbohydrate 6-O-sulfotransferase family (Seko, A. et al. (2002) Glycobiology 12, 379-388). Here, we prepared a GlcNAc6ST-2-specific polyclonal antibody for immunohistochemical analysis and found that GlcNAc6ST-2 is ectopically expressed by not only colonic mucinous adenocarcinomas but also ovarian mucinous, clear cell and papillary serous adenocarcinomas. In contrast, solid serous adenocarcinomas, endometrioid adenocarcinomas, and mucinous adenomas expressed GlcNAc6ST-2 much less frequently or not at all. RT-PCR analysis confirmed that GlcNAc6ST-2 transcripts are expressed in ovarian mucinous adenocarcinomas but not in mucinous adenomas. In addition, immunohistochemical analysis using sulfated glycan-specific monoclonal antibodies showed that ovarian adenocarcinoma cells express GlcNAc 6-O-sulfated glycans, including an L-selectin ligand and its related glycans. These results indicate that GlcNAc6ST-2 would be a novel tumor antigen that is specifically expressed in ovarian mucinous, clear cell and papillary serous adenocarcinomas.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0282-0080
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
23
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
453-60
|
pubmed:meshHeading |
pubmed-meshheading:16897186-Adenocarcinoma,
pubmed-meshheading:16897186-Adult,
pubmed-meshheading:16897186-Aged,
pubmed-meshheading:16897186-Antigens, Neoplasm,
pubmed-meshheading:16897186-Drug Resistance, Neoplasm,
pubmed-meshheading:16897186-Female,
pubmed-meshheading:16897186-Humans,
pubmed-meshheading:16897186-Immunohistochemistry,
pubmed-meshheading:16897186-Middle Aged,
pubmed-meshheading:16897186-Ovarian Neoplasms,
pubmed-meshheading:16897186-Sulfotransferases,
pubmed-meshheading:16897186-Tumor Cells, Cultured
|
pubmed:year |
2006
|
pubmed:articleTitle |
Ectopic expression of N-acetylglucosamine 6-O-sulfotransferase 2 in chemotherapy-resistant ovarian adenocarcinomas.
|
pubmed:affiliation |
Hanno Discovery Center, TAIHCO Pharmaceutical Co. Ltd., Saitama, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|